Nuvectis Pharma, Inc. (NVCT) vs OmniAb, Inc. (OABI)
Nuvectis Pharma, Inc. and OmniAb, Inc. are both Biotechnology companies. Nuvectis Pharma, Inc. and OmniAb, Inc. are of similar size ($706.1M and $697.9M). Nuvectis Pharma, Inc. has the higher net margin (0.00% vs −115.1%) and the higher return on invested capital (0.00% vs −14.5%). Across the 12 metrics below, OmniAb, Inc. leads on 7 and Nuvectis Pharma, Inc. on 5.
Valuation
Profitability
| Metric | NVCT | OABI | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 98.28% | 65.16% |
| Operating margin | 0.00% | (125.78%) | 0.00% |
| Net margin | 0.00% | (115.12%) | 0.00% |
| Free cash flow margin | 0.00% | (47.17%) | 0.00% |
| Return on equity | (233.30%) | (16.95%) | (57.72%) |
| Return on assets | (122.61%) | (15.11%) | (49.22%) |
| Return on invested capital | 0.00% | (14.52%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack